BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35950382)

  • 21. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases.
    Giberti C; Oneto F; Martorana G; Rovida S; Carmignani G
    Eur Urol; 1997; 31(1):40-8. PubMed ID: 9032533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and long-term prognosis of papillary renal cell carcinoma.
    Schrader AJ; Rauer-Bruening S; Olbert PJ; Hegele A; Rustemeier J; Timmesfeld N; Varga Z; Hofmann R
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):799-805. PubMed ID: 19023595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the papillary renal cell carcinoma subtype on oncological outcomes.
    Pan H; Ye L; Zhu Q; Yang Z; Hu M
    Sci Rep; 2020 Dec; 10(1):21073. PubMed ID: 33273677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.
    Basile G; Rosiello G; Larcher A; Fallara G; Martini A; Re C; Cignoli D; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Necchi A; Raggi D; Salonia A; Briganti A; Montorsi F; Capitanio U
    Urol Oncol; 2022 Aug; 40(8):384.e15-384.e21. PubMed ID: 35662498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
    Bigot P; Bernhard JC; Gill IS; Vuong NS; Verhoest G; Flamand V; Reix B; Suer E; Gökce I; Beauval JB; Nouhaud FX; Eto M; Baco E; Matsugasumi T; Chowaniec Y; Rigaud J; Lenormand C; Pfister C; Hetet JF; Ploussard G; Roupret M; Léon P; Bakri AE; Larré S; Tillou X; Doerfler A; Descazeaud A; Koutlidis N; Schneider A; Sebe P; Ingels A; Azzouzi AR; Soulié M; Méjean A; Bensalah K; Patard JJ;
    World J Urol; 2016 Mar; 34(3):347-52. PubMed ID: 26149352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomorphologic comparison of type 1 and type 2 papillary renal cell carcinoma: A retrospective analysis of 28 cases.
    Magers MJ; Perrino CM; Cramer HM; Wu HH
    Cancer Cytopathol; 2019 Jun; 127(6):370-376. PubMed ID: 31091016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis.
    Li J; Li Q; Yuan Y; Xie Y; Zhang Y; Zhang R
    BMC Urol; 2022 Sep; 22(1):157. PubMed ID: 36163007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological and prognostic characteristics of clear cell papillary renal cell carcinoma].
    Xu YW; Zhou JC; Xie HB; Yang WP; Li L; Zhang KN; Ma KF; Gong YQ; Zhang Z; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3784-3788. PubMed ID: 34895417
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
    Hutterer GC; Pichler M; Chromecki TF; Strini KA; Klatte T; Pummer K; Remzi M; Mannweiler S; Zigeuner R
    Histopathology; 2013 Sep; 63(3):309-15. PubMed ID: 23802739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.